Peter Kunach

The share of this author’s assessed papers carrying a ⚑ flag. A concentration is a prompt for expert review — never, on its own, a determination about the person.

Collaborators, sized by shared output and coloured by their own reproducibility (green = high, red = low). Click a node to open their card. A pattern is a prompt for review, never a determination.

How this author’s assessed papers reproduced — the outcome of reproduction attempts, not a judgement of the person. Coverage is partial and grows over time.

Assessed papers (1)

• Cross-species comparative hippocampal transcriptomics in Alzheimer's disease.
  2023 L1 75/100

1 assessed by us (1 reproduced) · 58 not yet assessed — every PubMed paper on record, linked below.

• A functional amyloid scaffold shapes insect egg coats ↗

  bioRxiv (Cold Spring Harbor Laboratory) · 2026 · PMID 42282606
  not yet assessed
• Hemispheric lateralization of Tau associations with visual and verbal memory in Alzheimer’s disease ↗

  European Journal of Nuclear Medicine and Molecular Imaging · 2026 · PMID 42243535
  not yet assessed
• Plasma phosphorylated tau217 strongly associates with memory deficits in the Alzheimer’s disease spectrum ↗

  Brain · 2025 · PMID 39879633
  not yet assessed
• Functional classification of tauopathy strains reveals the role of protofilament core residues ↗

  Science Advances · 2025 · PMID 39841851
  not yet assessed
• Tau profiling across Alzheimer’s disease staging reveals vulnerability to disease pathophysiology ↗

  European Journal of Nuclear Medicine and Molecular Imaging · 2025 · PMID 40274672
  not yet assessed
• Autoradiographic comparison between [11C]PiB and [18F]AZD4694 in human brain tissue ↗

  EJNMMI Research · 2025 · PMID 40167827
  not yet assessed
• Cryo-EM structure of Alzheimer’s disease tau filaments with PET ligand MK-6240 ↗

  Nature Communications · 2024 · PMID 39353896
  not yet assessed
• Predicting functional decline in aging and Alzheimer’s disease with PET-based Braak staging ↗

  Brain Communications · 2024 · PMID 38482373
  not yet assessed
• Docking for Molecules That Bind in a Symmetric Stack with SymDOCK ↗

  Journal of Chemical Information and Modeling · 2024 · PMID 38191997
  not yet assessed
• ATTRv-V30M amyloid fibrils from heart and nerves exhibit structural homogeneity ↗

  Structure · 2024 · PMID 39423808
  not yet assessed
• Comparison Between Brain and Cerebellar Autoradiography Using [¹⁸F]Flortaucipir, [¹⁸F]MK6240, and [¹⁸F]PI2620 in Postmortem Human Brain Tissue ↗

  Journal of Nuclear Medicine · 2024 · PMID 39477493
  not yet assessed
• Astrocyte reactivity and cerebral glucose hypermetabolism in early Alzheimer’s: insights from a longitudinal study in the TgF344‐AD rat model ↗

  Alzheimer s & Dementia · 2024 · PMID 39750874
  not yet assessed
• ATTRv-V30M Type A amyloid fibrils from heart and nerves exhibit structural homogeneity ↗

  bioRxiv (Cold Spring Harbor Laboratory) · 2024 · PMID 38798361
  not yet assessed
• Functional classification of tauopathy strains reveals the role of protofilament core residues ↗

  bioRxiv (Cold Spring Harbor Laboratory) · 2024
  not yet assessed
• Docking for molecules that bind in a symmetric stack to Alzheimer’s disease tau fibrils with SymDOCK ↗

  Biophysical Journal · 2024
  not yet assessed
• In vitro formation of amyloid fibrils from full-length transthyretin templated by ATTRv seeds PB14 (#370) ↗

  2024
  not yet assessed
• Visual memory is primarily impacted by tau load in the right hemisphere ↗

  Alzheimer s & Dementia · 2024 · PMID 39750247
  not yet assessed
• Neuroinflammation potentiates the effect of amyloid‐β on longitudinal tau changes ↗

  Alzheimer s & Dementia · 2024
  not yet assessed
• Visual memory is primarily impacted by tau load in the right hemisphere ↗

  Alzheimer s & Dementia · 2024
  not yet assessed
• Neuroinflammation potentiates the effect of amyloid‐β on longitudinal tau changes ↗

  Alzheimer s & Dementia · 2024
  not yet assessed
• Astrocyte reactivity and cerebral glucose hypermetabolism in early Alzheimer's: insights from a longitudinal study in the TgF344‐AD rat model ↗

  Alzheimer s & Dementia · 2024
  not yet assessed
• Verbal memory formation across PET-based Braak stages of tau accumulation in Alzheimer’s disease ↗

  Brain Communications · 2023 · PMID 37252014
  not yet assessed
• Cross-species comparative hippocampal transcriptomics in Alzheimer’s disease

  iScience · 2023 · PMID 38292167
  L1 75/100
• Amyloid beta plaque accumulation with longitudinal [18F]AZD4694 PET ↗

  Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · 2023 · PMID 37644990
  not yet assessed
• Cross‐species evidence of differential expression of S100A6 and SLC11A1 in the hippocampus of Alzheimer’s disease patients and mouse models ↗

  Alzheimer s & Dementia · 2023
  not yet assessed
• Independent associations of plasma GFAP with amyloid‐β and tau in Alzheimer’s disease ↗

  Alzheimer s & Dementia · 2023
  not yet assessed
• Cryo-EM structure of Alzheimer’s disease tau filaments with PET ligand MK-6240 ↗

  bioRxiv (Cold Spring Harbor Laboratory) · 2023 · PMID 37790438
  not yet assessed
• Docking for molecules that bind in a symmetric stack with SymDOCK ↗

  bioRxiv (Cold Spring Harbor Laboratory) · 2023 · PMID 37961414
  not yet assessed
• Effect of alpha‐Synuclein on the binding of [18F]MK‐6240 and [18F]AV‐1451 ↗

  Alzheimer s & Dementia · 2023
  not yet assessed
• Brain PET Imaging in Small Animals: Tracer Formulation, Data Acquisition, Image Reconstruction, and Data Analysis ↗

  Methods in molecular biology · 2023 · PMID 38006502
  not yet assessed
• Temporal evaluation of imaging and biofluid biomarkers, spatial neuropathology and glial function in the TgF344‐AD rat model ↗

  Alzheimer s & Dementia · 2023
  not yet assessed
• Interactions of synaptic and inflammatory biomarkers in Alzheimer’s Disease ↗

  Alzheimer s & Dementia · 2023
  not yet assessed
• Plasma biomarkers of tau for the differentiation between slow and fast tau‐PET accumulators ↗

  Alzheimer s & Dementia · 2023
  not yet assessed
• Plasma biomarkers of tau for the differentiation between slow and fast tau‐PET accumulators ↗

  Alzheimer s & Dementia · 2023
  not yet assessed
• Interactions of synaptic and inflammatory biomarkers in Alzheimer’s Disease ↗

  Alzheimer s & Dementia · 2023
  not yet assessed
• Pet-based Braak staging predicts neuropsychiatric burden and severity in aging and Alzheimer's disease ↗

  Journal of the Neurological Sciences · 2023
  not yet assessed
• Independent associations of plasma GFAP with amyloid-Β and tau in Alzheimer's disease ↗

  Journal of the Neurological Sciences · 2023
  not yet assessed
• Biomarker modeling of Alzheimer’s disease using PET-based Braak staging ↗

  Nature Aging · 2022 · PMID 37118445
  not yet assessed
• Association of Phosphorylated Tau Biomarkers With Amyloid Positron Emission Tomography vs Tau Positron Emission Tomography ↗

  JAMA Neurology · 2022 · PMID 36508198
  not yet assessed
• Comparing tau status determined via plasma pTau181, pTau231 and [18F]MK6240 tau-PET ↗

  EBioMedicine · 2022 · PMID 35134647
  not yet assessed
• Impact of meningeal and age‐related off‐target binding on longitudinal [¹⁸F]MK6240 quantification. ↗

  Alzheimer s & Dementia · 2022
  not yet assessed
• Adapting to reality: Effect of Online Assessments as Compared to In‐Person Assessments ↗

  Alzheimer s & Dementia · 2022
  not yet assessed
• Tau phosphorylation is more closely associated with amyloid‐β plaques than with tau neurofibrillary tangles ↗

  Alzheimer s & Dementia · 2022
  not yet assessed
• Longitudinal changes in brain glucose metabolism, astrocyte biomarkers and behavior in an APP/PS1 rat model ↗

  Alzheimer s & Dementia · 2022
  not yet assessed
• Verbal recognition declines in later Braak Stages compared to verbal delayed recall ↗

  Alzheimer s & Dementia · 2022
  not yet assessed
• Impact of meningeal and age‐related off‐target binding on longitudinal [¹⁸F]MK6240 quantification ↗

  Alzheimer s & Dementia · 2022
  not yet assessed
• Tau phosphorylation is more closely associated with amyloid‐β plaques than with tau neurofibrillary tangles ↗

  Alzheimer s & Dementia · 2022
  not yet assessed
• Discrepancy between plasma pTau181 and tau‐PET statuses ↗

  Alzheimer s & Dementia · 2021
  not yet assessed
• Cross-species comparative hippocampal transcriptomics in Alzheimer’s disease ↗

  bioRxiv (Cold Spring Harbor Laboratory) · 2021
  not yet assessed
• Effect of temporal meta‐ROI and Braak1&2 ROI on the dissociation between plasma pTau181 and PET statuses ↗

  Alzheimer s & Dementia · 2021
  not yet assessed
• Quantifying acute tau inoculations in living rats using PET ↗

  Alzheimer s & Dementia · 2021
  not yet assessed
• Feasibility of imaging tau inoculations using PET ↗

  McGill-DEV · 2021
  not yet assessed
• Quantifying acute tau inoculations in living rats using PET ↗

  Alzheimer s & Dementia · 2020
  not yet assessed
• Aβ34 is a BACE1-derived degradation intermediate associated with amyloid clearance and Alzheimer’s disease progression ↗

  Nature Communications · 2019 · PMID 31110178
  not yet assessed
• IC‐P‐146: THE TRANSLATIONAL BIOMARKERS IN AGING AND DEMENTIA: TRIAD, A BIOMARKER ORIENTED COHORT ↗

  Alzheimer s & Dementia · 2019
  not yet assessed
• P2‐346: TAU AND AMYLOID PATHOLOGY SUPPRESS GLOBAL BRAIN FUNCTIONAL CONNECTIVITY ↗

  Alzheimer s & Dementia · 2019
  not yet assessed
• IC‐P‐182: AMYLOID‐DEPENDENT AND AMYLOID‐INDEPENDENT EFFECTS OF TAU ON CLINICAL STATUS ↗

  Alzheimer s & Dementia · 2019
  not yet assessed
• IC‐P‐071: ASSOCIATIONS BETWEEN PLASMA NFL AND BRAIN ATROPHY IN ALZHEIMER'S DISEASE ↗

  Alzheimer s & Dementia · 2019
  not yet assessed
• P1‐274: ASSOCIATIONS BETWEEN PLASMA NFL AND BRAIN ATROPHY IN ALZHEIMER'S DISEASE ↗

  Alzheimer s & Dementia · 2019
  not yet assessed